Medienmitteilung

Vifor Pharma appoints heads of International Business Operations and Global Marketing

Dienstag, 16. September 2014, ↓ direkt zum Download

Vifor Pharma today announced the appointments of Dario Eklund as Head of International Business Operations (including North America) and Abdul Mullick as Head of Global Marketing. Both positions will report directly to the CEO of Vifor Pharma Søren Tulstrup and will be based at the headquarters in Zurich, Switzerland.

Dario Eklund joins Vifor Pharma from Organogenesis Inc. in Boston, USA, where he was Vice President with responsibility for non-US operations, business development and licensing and the Gintuit business unit. Prior to that, Mr. Eklund was General Manager of Aventis Pharma (now Sanofi) in Switzerland, which he joined after several roles of increasing responsibility, such as Commercial Director, Area Manager Eastern Europe & Israel and Country Manager, at Novartis in Basel. Mr. Eklund holds a master’s degree from the Swedish School of Economics and Business Administration in Helsinki, Finland.

Abdul Mullick was most recently Vice President and General Manager, endocrinology and cardiology, in the rare diseases division of Sanofi (formerly Genzyme) in Boston, where he led the US and international operations; and prior to this, he was responsible for global marketing for rare genetic diseases. Before moving to Boston, he spent several years with Genzyme in Europe where he led the endocrine and renal business unit in the Asia-Pacific region and the endocrine business unit in Europe. Before joining Genzyme, Mr. Mullick held a number of positions at Novartis, including Senior Global Brand Lead with responsibility for the diabetes franchise. Mr. Mullick has a Ph.D. in molecular biology from Bristol, England.

Vifor Pharma, ein Unternehmen der Galenica Gruppe, ist eine der weltweit führenden Gesellschaften im Bereich Erforschung, Entwicklung, Herstellung und Vermarktung von pharmazeutischen Produkten zur Behandlung von Eisenmangel. Das Unternehmen bietet zudem ein diversifiziertes Portfolio an verschreibungspflichtigen Medikamenten und nicht verschreibungspflichtigen (OTC) Produkten an. Vifor Pharma mit Sitz in Zürich, Schweiz, baut seine globale Präsenz laufend aus und verfügt über ein umfassendes Netzwerk aus Tochtergesellschaften und Partnern weltweit.

Kontakt

Beatrix Benz

Head of Global Communications & Public Affairs


Vifor Pharma AG

Global Communications
Flughofstrasse 61
Postfach
CH-8152 Glattbrugg

Tel:
+41 58 851 80 00
Fax:
+41 58 851 80 01

Link senden

Als Link versenden



Links